Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa
Abstract
In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from initiating life-saving ART.
Keywords
Type of publication